Duchesnay is a multinational pharmaceutical group dedicated to women’s health and other conditions, rare diseases and high-quality generic medicines.

Safeguarding the health of pregnant women and their babies

Duchesnay works to continuously advance maternal-fetal medicine and scientific knowledge to help women enjoy a healthy and joyful pregnancy, while reducing the risk of birth defects in their babies.

Ensuring women’s health at every stage of life

Duchesnay’s commitment to women’s health goes far beyond pregnancy and breastfeeding. That’s why we have broadened our portfolio of products to offer safe and effective therapeutic options that meet the health and quality of life needs of women and their family members at different stages of their lives.

Duchesnay Inc. is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal system, a new option for women.
Slynd® (drospirenone) is now covered by the Régie de l’assurance maladie du Québec
The CEO of Duchesnay Pharmaceutical Groupe, Éric Gervais, shared his thoughts on the future of the life sciences industry with Investment Reports.